The medical imaging reagents market is expected to show exponential growth. This is on account of growing consumer industries, including pharmaceuticals, life sciences and biotechnology and emergence of North America as a leading market. Medical imaging reagents are designed to improve the image through imaging devices.
The pivotal factors propelling the growth of medical imaging reagents market are rising aged population, technological improvements and augmented cardiovascular diseases and cancer cases. However, strict regulations regarding the approval of imaging reagent devices and lack of suppliers are expected to restrain the medical imaging reagents market.
The market segmentation for the medical imaging reagents market is based on classes, applications, technologies and geographies. On the basis of classes, the market can be split into nuclear reagents, optical reagents and contract reagents.
The applications medical imaging reagents market can be divided into drug discovery & developments, research & development and diagnostics. Drug discovery & developments are expected to drive the applications market.
The technologies medical imaging reagents market can be sliced into quantum dots, radiopharmaceuticals, nano particles, fluorescent dyes & probes and fluorescent proteins. Radiopharmaceuticals was the largest technology. Nano particles are experiencing steady growth.
Geographically, the medical imaging reagents market is fragmented into North America, Asia Pacific, Europe and rest of the world. North America leads the market and is followed by Europe. This is due to improvements in technology and rising cardiovascular diseases and cancer cases in North America.
Asia Pacific is projected to report the highest growth in the coming years. This is as a result of rising aged population and improvements in healthcare infrastructure
Posted on May 4, 2015 | Category Healthcare